Essential thrombocythemia, a clonal myeloproliferative neoplasm with excessive platelet production, is associated with an increased risk of thrombosis and bleeding. Author Ayalew Tefferi, MD, of the Mayo Clinic, joins JAMA Associate Editor David Simel, MD, MHS, to discuss diagnosis and treatment of this condition. Related Content: Essential Thrombocythemia
--------
23:17
USPSTF Recommendation: Screening for Osteoporosis to Prevent Fractures
Interview with Esa M. Davis, MD, MPH, USPSTF member and coauthor of Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content: Screening for Osteoporosis to Prevent Fractures Screening for Osteoporosis to Prevent Fractures Fracture Risk Assessment as a Component of Osteoporosis Screening—Easier Said Than Done Screening for Osteoporosis to Prevent Fractures
--------
10:52
Recent Developments in Women’s Health Research at the NIH
NIH'S policies, programs, and research funding fill gaps in knowledge about women’s health. Janine Austin Clayton, MD, of the NIH joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss key programs, policies, and scientific advances of the NIH that have informed and improved women’s health. Related Content: Recent Developments in Women’s Health Research at the US National Institutes of Health National Academies Report Calls for an NIH Institute Dedicated to Women’s Health
JAMA Deputy Editor Mary McDermott, MD, and JAMA Deputy Editor Kristin Walter, MD, MS, highlight their selections of top JAMA 2024 Clinical Reviews podcasts. Related Content: Dialysis for Chronic Kidney Failure (podcast) Diagnosis and Treatment of Community-Acquired Pneumonia (CAP) (podcast) Obesity Medications (podcast) Dialysis for Chronic Kidney Failure Community-Acquired Pneumonia Medications for Obesity
--------
22:04
Chronic Kidney Disease and Diabetes
Chronic kidney disease develops among 30% to 40% of people with type 1 or type 2 diabetes during their lifetime. Author Ian H. de Boer, MD, MS, of the University of Washington Division of Nephrology, discusses the evaluation and treatment of chronic kidney disease in patients with type 1 and type 2 diabetes with JAMA Senior Editor Karen Lasser, MD, MPH. Related Content: Diabetes and Chronic Kidney Disease
--------
18:03
More Health & Wellness podcastsMore Health & Wellness podcasts
South Africa